LFVN logo

Lifevantage Corporation (LFVN)

$4.77

Quotes are delayed by 15 minutes.

1D

1W

1M

3M

6M

YTD

1Y

2Y

5Y

ALL

Key data on LFVN

Market cap

$60494194

EPS

0.21

P/E ratio

15

Price to sales

0.41

Dividend yield

4.193%

Beta

0.712866

Price on LFVN

Previous close

$4.97

Today's open

$4.94

Day's range

$4.67 - $5.20

52 week range

$3.90 - $11.71

Profile about LFVN

CEO

Steven R. Fife

Employees

223

Headquarters

Lehi, UT

Exchange

NASDAQ Capital Market

Shares outstanding

12682221

Issue type

Common Stock

LFVN industries and sectors

Consumer Staples

Consumer Products - Healthcare

News on LFVN

LifeVantage Corporation (LFVN) Q1 2027 Earnings Call Transcript

LifeVantage Corporation (LFVN) Q1 2027 Earnings Call Transcript

news source

Seeking Alpha • Nov 10, 2026

news preview

What Lifevantage (LFVN) Said on Its Q1 Earnings Call

Lifevantage NASDAQ: LFVN reported a 22% decline in revenue for its fiscal first quarter and outlined a strategy to overhaul its brand, digital sales tools and cost structure as it works to stabilize the business.

news source

MarketBeat • Nov 9, 2026

news preview

LifeVantage Announces Financial Results for the First Quarter Fiscal 2027

SALT LAKE CITY, Nov. 09, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today reported financial results for its quarter ended September 30, 2026.  First Quarter Fiscal 2027 Summary*: Revenue was $37.1 million, a decrease of 22.0% from the prior year period; Revenue in the Americas decreased 22.2%, and revenue in Asia/Pacific & Europe decreased 21.2%; Net loss per diluted share was $0.02, versus net income per diluted share of $0.17 a year ago; Adjusted earnings per diluted share was $0.05, compared to $0.18 a year ago; and Adjusted EBITDA was $1.9 million compared to $3.9 million a year ago.

news source

GlobeNewsWire • Nov 9, 2026

news preview

LifeVantage Declares Quarterly Dividend

SALT LAKE CITY, Nov. 09, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that the Company's Board of Directors has approved a quarterly cash dividend of $0.050 per share of common stock, which will be paid December 15, 2026 to all stockholders of record at the close of business on December 1, 2026.

news source

GlobeNewsWire • Nov 9, 2026

news preview

Lifevantage (LFVN) Surpasses Q1 Earnings Estimates

Lifevantage (LFVN) came out with quarterly earnings of $0.05 per share, beating the Zacks Consensus Estimate of $0.03 per share. This compares to earnings of $0.18 per share a year ago.

news source

Zacks Investment Research • Nov 10, 2026

news preview

New LifeVantage Research Explores How Protandim® Nrf2 Supports Cellular Defense Against Five Modern Environmental Toxins*

SALT LAKE CITY, Oct. 29, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation® (Nasdaq: LFVN) continues to lead the next generation of healthy aging with its latest in vitro research study examining how five modern environmental toxins—pollution, microplastics, ultra-processed foods, hormone disruptors, and pesticides—affect cells and the role Protandim® Nrf2 can play in helping protect against their impact. † These findings further reinforce LifeVantage's position as a pioneer in nutrigenomics and the science behind its products that ignite the human body's natural defense systems.

news source

GlobeNewsWire • Oct 29, 2026

news preview

LifeVantage to Announce First Quarter Fiscal Year 2027 Results on November 9, 2026

SALT LAKE CITY, Oct. 26, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN) a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that it will release financial results for its first quarter ended September 30, 2026, after the stock market closes on Monday, November 9, 2026. The Company will hold a conference call for investors at 2:30 p.m. Mountain Time (4:30 p.m. Eastern Time) that same day.

news source

GlobeNewsWire • Oct 26, 2026

news preview

New Strong Sell Stocks for October 19th

CWH, LFVN and CGAU have been added to the Zacks Rank #5 (Strong Sell) List on October 19, 2026.

news source

Zacks Investment Research • Oct 19, 2026

news preview

LifeVantage Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

SALT LAKE CITY, Oct. 12, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN) (“LifeVantage” or the “Company”) today announced that its Board of Directors granted inducement awards to Terrence Moorehead, the Company's President and Chief Executive Officer, under the Company's 2026 New Employee Long-Term Incentive Plan. The awards were granted pursuant to the key executive benefits agreement between the Company and Mr. Moorehead, dated as of April 15, 2026, as an inducement material to Mr. Moorehead's employment in accordance with Nasdaq Listing Rule 5635(c)(4).

news source

GlobeNewsWire • Oct 12, 2026

news preview

LifeVantage Unveils Turnaround Plan to Rebuild Brand, Margins and Growth

Lifevantage NASDAQ: LFVN executives outlined a turnaround plan centered on strengthening the company's brand, improving consumer relevance and increasing operating efficiency during a Water Tower Research conference discussion.

news source

MarketBeat • Sep 24, 2026

news preview

¹ Disclosures

Get started with M1

Invest in Lifevantage Corporation

Open an M1 investment account to buy and sell Lifevantage Corporation commission-free¹. Build wealth for the long term using automated trading and transfers.

Invest in LFVN on M1